Reversible Cerebral Vasoconstriction Syndrome
Also known as: RCVS, Call-Fleming Syndrome
Reversible cerebral vasoconstriction syndrome is recurrent thunderclap headache, with or without focal deficits or seizures, associated with multifocal segmental vasoconstriction of cerebral arteries that resolves spontaneously within 3 months.
Epidemiology. It most often affects women aged 20 to 50 years, and occurs in the postpartum period. It may be underdiagnosed. Complications occur in 20 to 40% (convexity subarachnoid haemorrhage, intracerebral haemorrhage, ischaemic stroke, posterior reversible encephalopathy syndrome). Death and permanent disability are uncommon.
Triggers. Postpartum state and pre-eclampsia, serotonergic drugs (selective serotonin reuptake inhibitors, serotonin and noradrenaline reuptake inhibitors), triptans and ergots, cannabis, cocaine and amphetamines, nasal decongestants (pseudoephedrine), blood products, immunosuppressants (tacrolimus, ciclosporin), phaeochromocytoma, sexual activity, exertion, straining, cold exposure and emotional stress. About half have no trigger.
Pathophysiology. Transient dysregulation of cerebral vascular tone with sympathetic overactivity, endothelial dysfunction and oxidative stress is proposed. Segmental narrowing and dilation appear in a "string of beads" pattern and peak at 2 to 3 weeks, with a lag after headache onset.













